SOURCE: Nutter McClennen & Fish LLP

Nutter McClennen & Fish LLP

December 05, 2011 11:01 ET

Former Pfizer Senior Corporate Counsel Joins Nutter

Nutter Expands Its Biotech/Pharma Intellectual Property Practice With the Addition of Konstantin Linnik

BOSTON, MA--(Marketwire - Dec 5, 2011) - The law firm of Nutter McClennen & Fish LLP announced that Konstantin Linnik, Ph.D., has joined the firm as a partner in the Intellectual Property group. He will use his extensive industry expertise to benefit biotechnology, pharmaceutical, and medical device clients and support their innovation goals. His work will focus on IP strategy; competitive analysis; patent portfolio development, licensing, enforcement and patent litigation. Before joining Nutter, Linnik was senior corporate counsel at Pfizer, the world's largest pharmaceutical company, where he was lead patent counsel for Pfizer research units in the US, Canada, and Germany.

"Coming from an industry leader, Konstantin offers our clients the immediate experience and insights into the intellectual property issues faced by major pharmaceutical companies," said William C. Geary III, co-managing partner of Nutter. "Adding Konstantin expands the biotech and pharma depth of our intellectual property team. This addition is part of our overall strategy to bring experienced and innovative legal counsel to pharma and biotech companies that are looking to maximize the opportunities that come with intellectual property."

Before joining Pfizer, Linnik represented a number of biotechnology and pharmaceutical companies as external counsel. Aside from his legal training, Linnik earned a Ph.D. in cell biology from Boston University School of Medicine. Linnik is active in the Boston legal community and currently chairs the Biotechnology Committee of the Boston Patent Law Association.

About Nutter McClennen & Fish LLP
Nutter McClennen & Fish LLP represents an international roster of innovative clients involved in a range of sophisticated technologies in the medical device, biotechnology and pharmaceutical industries, as well as renowned medical institutions and research universities, emerging growth companies and angel and venture capital firms. The firm's expertise spans IP strategy, prosecution and litigation; strategic collaborations and licensing; clinical trials and regulatory compliance; as well as M&A, capital raising and finance, government investigations and defense, and product liability. Nutter was co-founded in 1879 by Louis D. Brandeis, who later became one of the most celebrated justices of the U.S. Supreme Court in modern times.

Contact Information

  • Contact:
    Lisa Jentzen